This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tazaki, Y. Articles by Sakuma, A. Search for Related Content PubMed PubMed Citation Articles by Tazaki, Y. Articles by Sakuma, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLINE BITARTRATE CHOLINE CHLORIDE

Stroke, Vol 19, 211-216, Copyright © 1988 by American Heart Association

ARTICLES

Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study

Y Tazaki, F Sakai, E Otomo, T Kutsuzawa, M Kameyama, T Omae, M Fujishima and A Sakuma
Department of Medicine, Kitasato University, Sagamihara, Japan.

A multicenter double-blind placebo-controlled study of cytidine 5'- diphosphocholine (CDP-choline) was conducted to evaluate possible clinical benefits of the drug in patients with acute, moderate to severe cerebral infarction. The patients included also suffered from moderate to mild disturbances of consciousness, and all were admitted within 14 days of the ictus. Patients were allocated randomly to treatment with either CDP-choline (1,000 mg/day i.v. once daily for 14 days) or with placebo (physiological saline). One hundred thirty-three patients received CDP-choline treatment, and 139 received placebo. The group treated with CDP-choline showed significant improvements in level of consciousness compared with the placebo-treated group, and CDP- choline was an entirely safe treatment.

This article has been cited by other articles:

				M. Fisher, A. Davalos, A. Rogalewski, A. Schneider, E. B. Ringelstein, and W.-R. Schabitz Toward a Multimodal Neuroprotective Treatment of Stroke Stroke, April 1, 2006; 37(4): 1129 - 1136. [Abstract] [Full Text] [PDF]

				C. S. Weaver, J. Leonardi-Bee, F. J. Bath-Hextall, and P. M.W. Bath Sample Size Calculations in Acute Stroke Trials: A Systematic Review of Their Reporting, Characteristics, and Relationship With Outcome Stroke, May 1, 2004; 35(5): 1216 - 1224. [Abstract] [Full Text] [PDF]

				A. Davalos, J. Castillo, J. Alvarez-Sabin, J. J. Secades, J. Mercadal, S. Lopez, E. Cobo, S. Warach, D. Sherman, W. M. Clark, et al. Oral Citicoline in Acute Ischemic Stroke: An Individual Patient Data Pooling Analysis of Clinical Trials Stroke, December 1, 2002; 33(12): 2850 - 2857. [Abstract] [Full Text] [PDF]

				W. M. Clark, L. R. Wechsler, L. A. Sabounjian, and U. E. Schwiderski A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients Neurology, November 13, 2001; 57(9): 1595 - 1602. [Abstract] [Full Text] [PDF]

				M. Fisher and W. Schaebitz An Overview of Acute Stroke Therapy: Past, Present, and Future Arch Intern Med, November 27, 2000; 160(21): 3196 - 3206. [Full Text] [PDF]

				W. M. Clark, B. J. Williams, K. A. Selzer, R. M. Zweifler, L. A. Sabounjian, and R. E. Gammans A Randomized Efficacy Trial of Citicoline in Patients With Acute Ischemic Stroke Stroke, December 1, 1999; 30(12): 2592 - 2597. [Abstract] [Full Text] [PDF]

				M. Andersen, K. Overgaard, P. Meden, G. Boysen, and S. C. Choi Effects of Citicoline Combined With Thrombolytic Therapy in a Rat Embolic Stroke Model • Editorial Comment Stroke, July 1, 1999; 30(7): 1464 - 1471. [Abstract] [Full Text] [PDF]

				W. R. Schabitz, F. Li, K. Irie, B. W. Sandage Jr, K. W. Locke, M. Fisher, and P. D. Hurn Synergistic Effects of a Combination of Low-Dose Basic Fibroblast Growth Factor and Citicoline After Temporary Experimental Focal Ischemia • Editorial Comment Stroke, February 1, 1999; 30(2): 427 - 432. [Abstract] [Full Text] [PDF]

				M. Z. Onal, F. Li, T. Tatlisumak, K. W. Locke, B. W. Sandage Jr, and M. Fisher Synergistic Effects of Citicoline and MK-801 in Temporary Experimental Focal Ischemia in Rats Stroke, May 1, 1997; 28(5): 1060 - 1065. [Abstract] [Full Text]